Bevacizumab/doxorubicin: Myelosuppression and hypertension: 3 case reports
Reactions weekly, 2022, Vol.1888 (1), p.103-103
Cham: Springer International Publishing
Full text available
- Searching for
- inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
- Show me what you have so far